Author: James W. Goding
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 344
Book Description
This book represents the distillation and critical evaluation of many hundreds of publications relating to the production and use of antibodies. Therefore it is restricted to the "core" techniques of production and handling of antibodies, and their use in studies of antigen analysis, purification and localization.
Monoclonal Antibodies
Author: James W. Goding
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 344
Book Description
This book represents the distillation and critical evaluation of many hundreds of publications relating to the production and use of antibodies. Therefore it is restricted to the "core" techniques of production and handling of antibodies, and their use in studies of antigen analysis, purification and localization.
Publisher:
ISBN:
Category : Medical
Languages : en
Pages : 344
Book Description
This book represents the distillation and critical evaluation of many hundreds of publications relating to the production and use of antibodies. Therefore it is restricted to the "core" techniques of production and handling of antibodies, and their use in studies of antigen analysis, purification and localization.
Monoclonal Antibody Production
Author: National Research Council
Publisher: National Academies Press
ISBN: 0309173051
Category : Medical
Languages : en
Pages : 74
Book Description
The American Anti-Vivisection Society (AAVS) petitioned the National Institutes of Health (NIH) on April 23, 1997, to prohibit the use of animals in the production of mAb. On September 18, 1997, NIH declined to prohibit the use of mice in mAb production, stating that "the ascites method of mAb production is scientifically appropriate for some research projects and cannot be replaced." On March 26, 1998, AAVS submitted a second petition, stating that "NIH failed to provide valid scientific reasons for not supporting a proposed ban." The office of the NIH director asked the National Research Council to conduct a study of methods of producing mAb. In response to that request, the Research Council appointed the Committee on Methods of Producing Monoclonal Antibodies, to act on behalf of the Institute for Laboratory Animal Research of the Commission on Life Sciences, to conduct the study. The 11 expert members of the committee had extensive experience in biomedical research, laboratory animal medicine, animal welfare, pain research, and patient advocacy (Appendix B). The committee was asked to determine whether there was a scientific necessity for the mouse ascites method; if so, whether the method caused pain or distress; and, if so, what could be done to minimize the pain or distress. The committee was also asked to comment on available in vitro methods; to suggest what acceptable scientific rationale, if any, there was for using the mouse ascites method; and to identify regulatory requirements for the continued use of the mouse ascites method. The committee held an open data-gathering meeting during which its members summarized data bearing on those questions. A 1-day workshop (Appendix A) was attended by 34 participants, 14 of whom made formal presentations. A second meeting was held to finalize the report. The present report was written on the basis of information in the literature and information presented at the meeting and the workshop.
Publisher: National Academies Press
ISBN: 0309173051
Category : Medical
Languages : en
Pages : 74
Book Description
The American Anti-Vivisection Society (AAVS) petitioned the National Institutes of Health (NIH) on April 23, 1997, to prohibit the use of animals in the production of mAb. On September 18, 1997, NIH declined to prohibit the use of mice in mAb production, stating that "the ascites method of mAb production is scientifically appropriate for some research projects and cannot be replaced." On March 26, 1998, AAVS submitted a second petition, stating that "NIH failed to provide valid scientific reasons for not supporting a proposed ban." The office of the NIH director asked the National Research Council to conduct a study of methods of producing mAb. In response to that request, the Research Council appointed the Committee on Methods of Producing Monoclonal Antibodies, to act on behalf of the Institute for Laboratory Animal Research of the Commission on Life Sciences, to conduct the study. The 11 expert members of the committee had extensive experience in biomedical research, laboratory animal medicine, animal welfare, pain research, and patient advocacy (Appendix B). The committee was asked to determine whether there was a scientific necessity for the mouse ascites method; if so, whether the method caused pain or distress; and, if so, what could be done to minimize the pain or distress. The committee was also asked to comment on available in vitro methods; to suggest what acceptable scientific rationale, if any, there was for using the mouse ascites method; and to identify regulatory requirements for the continued use of the mouse ascites method. The committee held an open data-gathering meeting during which its members summarized data bearing on those questions. A 1-day workshop (Appendix A) was attended by 34 participants, 14 of whom made formal presentations. A second meeting was held to finalize the report. The present report was written on the basis of information in the literature and information presented at the meeting and the workshop.
Monoclonal Antibodies
Author: Roger H. Kennett
Publisher: Springer Science & Business Media
ISBN: 1461575052
Category : Medical
Languages : en
Pages : 423
Book Description
On August 7, 1975, Kohler and Milstein published in Nature (256:495) a report describing "Continuous cultures of fused cells secreting antibody of predefined specificity. " Their report has become a classic and has already had a profound effect on basic and applied research in biology and medicine. By the time the first Workshop on Lymphocyte Hybridomas (Current Topics in Microbiology and Im munology 81, 1978) was held on April 3-5, 1978, in Bethesda, Maryland, investi gators from many laboratories had made hybrids between plasmacytomas and spleen cells from immunized animals and had obtained monoclonal antibodies reacting with a broad variety of antigenic determinants. At the time Kohler and Milstein introduced this new technology, the editors of this volume were involved in the production of antisera against differentiation antigens (K. B. B. ), histocompatibility antigens (T. ]. McK. ), and human tumor associated antigens (R. H. K. ). Because of the potential usefulness of monoclonal antibodies in these areas, we each began production of hybridomas and analysis of the resulting monoclonal reagents. One of the most interesting aspects of participation in the early stages of the development and application of hybrid oma technology has been observing how the implications of the initial observa tions gradually spread first among the practitioners of immunology and immu nogenetics, and then to other areas of the biological sciences, such as developmental biology, biochemistry, human genetics, and cell and tumor biology.
Publisher: Springer Science & Business Media
ISBN: 1461575052
Category : Medical
Languages : en
Pages : 423
Book Description
On August 7, 1975, Kohler and Milstein published in Nature (256:495) a report describing "Continuous cultures of fused cells secreting antibody of predefined specificity. " Their report has become a classic and has already had a profound effect on basic and applied research in biology and medicine. By the time the first Workshop on Lymphocyte Hybridomas (Current Topics in Microbiology and Im munology 81, 1978) was held on April 3-5, 1978, in Bethesda, Maryland, investi gators from many laboratories had made hybrids between plasmacytomas and spleen cells from immunized animals and had obtained monoclonal antibodies reacting with a broad variety of antigenic determinants. At the time Kohler and Milstein introduced this new technology, the editors of this volume were involved in the production of antisera against differentiation antigens (K. B. B. ), histocompatibility antigens (T. ]. McK. ), and human tumor associated antigens (R. H. K. ). Because of the potential usefulness of monoclonal antibodies in these areas, we each began production of hybridomas and analysis of the resulting monoclonal reagents. One of the most interesting aspects of participation in the early stages of the development and application of hybrid oma technology has been observing how the implications of the initial observa tions gradually spread first among the practitioners of immunology and immu nogenetics, and then to other areas of the biological sciences, such as developmental biology, biochemistry, human genetics, and cell and tumor biology.
Administrations of Lunacy
Author: Mab Segrest
Publisher: The New Press
ISBN: 1620972980
Category : Medical
Languages : en
Pages : 378
Book Description
"Whew! They going to send around here and tie you up and drag you off to Milledgeville. Them fat blue police chasing tomcats around alleys." —Berenice in The Member of the Wedding by Carson McCullers A scathing and original look at the racist origins of the field of modern psychiatry, told through the story of what was once the largest mental institution in the world, by the prize-winning author of Memoir of a Race Traitor After a decade of research, Mab Segrest, whose Memoir of a Race Traitor forever changed the way we think about race in America, turns sanity itself inside-out in a stunning book that will become an instant classic. In December 1841, the Georgia State Lunatic, Idiot, and Epileptic Asylum was founded on land taken from the Cherokee nation in the then-State capitol of Milledgeville. A hundred years later, it had become the largest insane asylum in the world with over ten thousand patients. To this day, it is the site of the largest graveyard of disabled and mentally ill people in the world. In April, 1949, Ebony magazine reported that for black patients, "the situation approaches Nazi concentration camp standards . . . unbelievable this side of Dante's Inferno." Georgia's state hospital was at the center of psychiatric practice and the forefront of psychiatric thought throughout the nineteenth and twentieth centuries in America—centuries during which the South invented, fought to defend, and then worked to replace the most developed slave culture since the Roman Empire. A landmark history of a single insane asylum at Milledgeville, Georgia, A Peculiar Inheritance reveals how modern-day American psychiatry was forged in the traumas of slavery, the Civil War, and Reconstruction, when African Americans carrying "no histories" entered from Freedmen's Bureau Hospitals and home counties wracked with Klan terror. This history set the stage for the eugenics and degeneracy theories of the twentieth century, which in turn became the basis for much of Nazi thinking in Europe. Segrest's masterwork will forever change the way we think about our own minds.
Publisher: The New Press
ISBN: 1620972980
Category : Medical
Languages : en
Pages : 378
Book Description
"Whew! They going to send around here and tie you up and drag you off to Milledgeville. Them fat blue police chasing tomcats around alleys." —Berenice in The Member of the Wedding by Carson McCullers A scathing and original look at the racist origins of the field of modern psychiatry, told through the story of what was once the largest mental institution in the world, by the prize-winning author of Memoir of a Race Traitor After a decade of research, Mab Segrest, whose Memoir of a Race Traitor forever changed the way we think about race in America, turns sanity itself inside-out in a stunning book that will become an instant classic. In December 1841, the Georgia State Lunatic, Idiot, and Epileptic Asylum was founded on land taken from the Cherokee nation in the then-State capitol of Milledgeville. A hundred years later, it had become the largest insane asylum in the world with over ten thousand patients. To this day, it is the site of the largest graveyard of disabled and mentally ill people in the world. In April, 1949, Ebony magazine reported that for black patients, "the situation approaches Nazi concentration camp standards . . . unbelievable this side of Dante's Inferno." Georgia's state hospital was at the center of psychiatric practice and the forefront of psychiatric thought throughout the nineteenth and twentieth centuries in America—centuries during which the South invented, fought to defend, and then worked to replace the most developed slave culture since the Roman Empire. A landmark history of a single insane asylum at Milledgeville, Georgia, A Peculiar Inheritance reveals how modern-day American psychiatry was forged in the traumas of slavery, the Civil War, and Reconstruction, when African Americans carrying "no histories" entered from Freedmen's Bureau Hospitals and home counties wracked with Klan terror. This history set the stage for the eugenics and degeneracy theories of the twentieth century, which in turn became the basis for much of Nazi thinking in Europe. Segrest's masterwork will forever change the way we think about our own minds.
Drug-Induced Liver Injury
Author:
Publisher: Academic Press
ISBN: 0128173173
Category : Medical
Languages : en
Pages : 290
Book Description
Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. - Includes the authority and expertise of leading contributors in pharmacology - Presents the latest release in the Advances in Pharmacology series
Publisher: Academic Press
ISBN: 0128173173
Category : Medical
Languages : en
Pages : 290
Book Description
Drug-Induced Liver Injury, Volume 85, the newest volume in the Advances in Pharmacology series, presents a variety of chapters from the best authors in the field. Chapters in this new release include Cell death mechanisms in DILI, Mitochondria in DILI, Primary hepatocytes and their cultures for the testing of drug-induced liver injury, MetaHeps an alternate approach to identify IDILI, Autophagy and DILI, Biomarkers and DILI, Regeneration and DILI, Drug-induced liver injury in obesity and nonalcoholic fatty liver disease, Mechanisms of Idiosyncratic Drug-Induced Liver Injury, the Evaluation and Treatment of Acetaminophen Toxicity, and much more. - Includes the authority and expertise of leading contributors in pharmacology - Presents the latest release in the Advances in Pharmacology series
The Mab
Author: Matt Brown
Publisher: Unbound Publishing
ISBN: 1800181167
Category : Juvenile Fiction
Languages : en
Pages : 226
Book Description
‘These stories make the wall between worlds thrillingly thin. Their enchantment calls to us ever from the other side of the door’ Michael Sheen, from the foreword If you think you’ve heard all the fairy tales out there, think again. Inside this book you will find eleven epic Welsh tales from long ago, but not so far away, that are bound to enchant you. The Mab is a collection full to the brim with brand new versions of really, really old stories from the Mabinogi – maybe the oldest written-down stories in the history of Britain. But as well as being really, really old, the stories in The Mab are strange and funny and thrilling. Alive with mystery and magic, they speak of a time when the gates between the Real World and the Otherworld were occasionally left open. And sometimes, just sometimes, it was possible to step through. The stories in this illustrated edition have been reimagined by an extraordinary team of writers, and each appears alongside a Welsh-language translation.
Publisher: Unbound Publishing
ISBN: 1800181167
Category : Juvenile Fiction
Languages : en
Pages : 226
Book Description
‘These stories make the wall between worlds thrillingly thin. Their enchantment calls to us ever from the other side of the door’ Michael Sheen, from the foreword If you think you’ve heard all the fairy tales out there, think again. Inside this book you will find eleven epic Welsh tales from long ago, but not so far away, that are bound to enchant you. The Mab is a collection full to the brim with brand new versions of really, really old stories from the Mabinogi – maybe the oldest written-down stories in the history of Britain. But as well as being really, really old, the stories in The Mab are strange and funny and thrilling. Alive with mystery and magic, they speak of a time when the gates between the Real World and the Otherworld were occasionally left open. And sometimes, just sometimes, it was possible to step through. The stories in this illustrated edition have been reimagined by an extraordinary team of writers, and each appears alongside a Welsh-language translation.
Monoclonal Antibodies
Author: Steven Shire
Publisher: Woodhead Publishing
ISBN: 0081002971
Category : Medical
Languages : en
Pages : 227
Book Description
Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophysical methods combined with genetic engineering is used to understand the solution properties of the formulation. The latter has become very important since many indications such as arthritis and asthma require the development of formulations for subcutaneous delivery (SC). The development of formulations for IV delivery is also important and comes with a different set of challenges. The challenges and strategies that can overcome these limitations are discussed in this book, starting with an introduction to these issues, followed by chapters detailing strategies to deal with them. Subsequent chapters explore the processing and storage of mAbs, development of delivery device technologies and conclude with a chapter on the future of mAbs in therapeutic remedies. - Discusses the challenges to develop MAbs for intravenous (IV) and subcutaneous delivery (SC) - Presents strategies to meet the challenges in development of MAbs for SC and IV administration - Discusses the use of biophysical analytical tools coupled with MAb engineering to understand what governs MAb properties at high concentration
Publisher: Woodhead Publishing
ISBN: 0081002971
Category : Medical
Languages : en
Pages : 227
Book Description
Monoclonal antibodies (MAbs) are currently the major class of protein bio therapeutic being developed by biotechnology and pharmaceutical companies. Monoclonal Antibodies discusses the challenges and issues revolving around development of a monoclonal antibody produced by recombinant DNA technology into a therapeutic agent.This book covers downstream processing which includes design of processes to manufacture the formulation, formulation design, fill and finish into closure systems and routes of administration. The characterization of the final drug product is covered where the use of biophysical methods combined with genetic engineering is used to understand the solution properties of the formulation. The latter has become very important since many indications such as arthritis and asthma require the development of formulations for subcutaneous delivery (SC). The development of formulations for IV delivery is also important and comes with a different set of challenges. The challenges and strategies that can overcome these limitations are discussed in this book, starting with an introduction to these issues, followed by chapters detailing strategies to deal with them. Subsequent chapters explore the processing and storage of mAbs, development of delivery device technologies and conclude with a chapter on the future of mAbs in therapeutic remedies. - Discusses the challenges to develop MAbs for intravenous (IV) and subcutaneous delivery (SC) - Presents strategies to meet the challenges in development of MAbs for SC and IV administration - Discusses the use of biophysical analytical tools coupled with MAb engineering to understand what governs MAb properties at high concentration
Monoclonal Antibodies
Author: Harleen Kaur
Publisher: Elsevier
ISBN: 0128223197
Category : Medical
Languages : en
Pages : 260
Book Description
Monoclonal antibodies (mAbs) are naturally occurring complex biomolecules. New engineering methods have turned mAbs into a leading therapeutic modality for addressing immunotherapeutic challenges and led to the rise of mAbs as the dominant class of protein therapeutics. mAbs have already demonstrated a great potential in developing safe and reliable treatments for complex diseases and creating more affordable healthcare alternatives. Developing mAbs into well-characterized antibody therapeutics that meet regulatory expectations, however, is extremely challenging. Obstacles to overcome include the determination and development of physiochemical characteristics such as aggregation, fragmentation, charge variants, identity, carbohydrate structure, and higher-order structure (HOS). This book dives deep into mAbs structure and the array of physiochemical testing and characterization methods that need to be developed and validated to establish a mAb as a therapeutic molecule. The main focus of this book is on physiochemical aspects, including the importance of establishing quality attributes such as glycosylation, primary sequence, purity, and HOS and elucidating the structure of new antibody formats by mass spectrometry. Each of the aforementioned quality attributes has been discussed in detail; this will help scientists in researching and developing biopharmaceuticals and biosimilars to find practical solutions to physicochemical testing and characterization. - Describes the spectrum of analytical tests and characterization methods necessary for developing and releasing mAb batches - Details antibody heterogeneity in terms of size, charge, and carbohydrate content - Gives special focus to the structural analysis of mAbs, including mass spectrometry analysis - Presents the basic structure of mAbs with clarity and rigor - Addresses regulatory guidelines - including ICH Q6B - in relation to quality attributes - Lays out characterization and development case studies including biosimilars and new antibody formats
Publisher: Elsevier
ISBN: 0128223197
Category : Medical
Languages : en
Pages : 260
Book Description
Monoclonal antibodies (mAbs) are naturally occurring complex biomolecules. New engineering methods have turned mAbs into a leading therapeutic modality for addressing immunotherapeutic challenges and led to the rise of mAbs as the dominant class of protein therapeutics. mAbs have already demonstrated a great potential in developing safe and reliable treatments for complex diseases and creating more affordable healthcare alternatives. Developing mAbs into well-characterized antibody therapeutics that meet regulatory expectations, however, is extremely challenging. Obstacles to overcome include the determination and development of physiochemical characteristics such as aggregation, fragmentation, charge variants, identity, carbohydrate structure, and higher-order structure (HOS). This book dives deep into mAbs structure and the array of physiochemical testing and characterization methods that need to be developed and validated to establish a mAb as a therapeutic molecule. The main focus of this book is on physiochemical aspects, including the importance of establishing quality attributes such as glycosylation, primary sequence, purity, and HOS and elucidating the structure of new antibody formats by mass spectrometry. Each of the aforementioned quality attributes has been discussed in detail; this will help scientists in researching and developing biopharmaceuticals and biosimilars to find practical solutions to physicochemical testing and characterization. - Describes the spectrum of analytical tests and characterization methods necessary for developing and releasing mAb batches - Details antibody heterogeneity in terms of size, charge, and carbohydrate content - Gives special focus to the structural analysis of mAbs, including mass spectrometry analysis - Presents the basic structure of mAbs with clarity and rigor - Addresses regulatory guidelines - including ICH Q6B - in relation to quality attributes - Lays out characterization and development case studies including biosimilars and new antibody formats
Memoir of a Race Traitor
Author: Mab Segrest
Publisher: South End Press
ISBN: 9780896084742
Category : Civil rights movements
Languages : en
Pages : 294
Book Description
'Courageous and daring, this work documents the reality that political solidarity, forged in struggle, can exist across difference.' bell hooks
Publisher: South End Press
ISBN: 9780896084742
Category : Civil rights movements
Languages : en
Pages : 294
Book Description
'Courageous and daring, this work documents the reality that political solidarity, forged in struggle, can exist across difference.' bell hooks
Therapeutic Monoclonal Antibodies
Author: Zhiqiang An
Publisher: John Wiley & Sons
ISBN: 1118210263
Category : Science
Languages : en
Pages : 932
Book Description
70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies. First book to address the discovery and development of antibody therapeutics in their entirety. Most chapters contain experimental data to illustrate the principles described in them. Authors provide detailed methodologies that readers can take away with them and use in their own laboratories.
Publisher: John Wiley & Sons
ISBN: 1118210263
Category : Science
Languages : en
Pages : 932
Book Description
70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies. First book to address the discovery and development of antibody therapeutics in their entirety. Most chapters contain experimental data to illustrate the principles described in them. Authors provide detailed methodologies that readers can take away with them and use in their own laboratories.